EMA Authorised: Resolor (prucalopride succinate) — Takeda Pharmaceuticals International AG Ireland

View source ↗

Summary

The European Medicines Agency authorised Resolor (prucalopride succinate) for the treatment of constipation, granting marketing authorization to Takeda Pharmace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Resolor (prucalopride)

Snippet

Status: Authorised. Therapeutic area: Constipation. MAH: Takeda Pharmaceuticals International AG Ireland. Decision date: 14/12/2022